Skip to main content
Epilepsy Currents logoLink to Epilepsy Currents
. 2001 Sep;1(1):1–5. doi: 10.1046/j.1535-7597.2001.00009.x

The GABAA Receptor: Subunit-Dependent Functions and Absence Seizures

C Guin-Ting Wong 1,4,1,4, O Carter Snead III 1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4
PMCID: PMC320684  PMID: 15309029

Abstract

GABAA receptors on thalamic relay and reticular (nRT) neurons play a critical role in thalamocortical mechanisms underlying absence seizures. Studies with absence seizure-prone rats and transgenic mice have taken advantage of differences in the subunit compositions of GABAA receptors in the two thalamic cell populations to clarify thalamocortical rhythm generating mechanisms and explain the antiabsence activity of benzodiazepines. The relevance of this work is highlighted by the recent finding of a mutation in the GABAA receptor γ2 subunit in a family with childhood absence seizures.

Introduction

γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system (CNS) where fast inhibitory neurotransmission is mediated by the GABAA receptor (GABAAR), a ligand-gated Cl channel. The GABAAR is a heteromeric pentamer, the function of which is dependent on subunit composition 1, 2. Currently, 20 GABAAR subunits have been identified in mammalian tissue, including six α, four β, three γ, one δ, one ε, one π, one θ, and three ρ subunits 3, 4. Based on the presence or absence of a short polypeptide sequence in the second intracellular loop, long and short splice variants, designated L and S, respectively, have been reported for γ2, β2, and β4 subunits. Alternative splicing also results in two different extreme amino-terminal ends for the β3 subunit.

The potential combinations of at least 23 subunit forms create a bewildering array of potential subunit combinations; however, in the endoplasmic reticulum and golgi apparatus, a restricted number of subunit combinations assemble together and are properly packaged, processed, and trafficked to the cell surface 5. In mammalian CNS, the GABAA R is believed to be composed of α, β, or β and θ, plus one or more of the γ, δ, ε subunits 3, 4. The α1β2β2 combination accounts for approximately 43% of GABAAR 6, although individual subunits display distinct regional neuronal and subcellular localization characteristics 7, 8, 9.

GABAA R Subtypes in Thalamocortical Circuitry

The GABAAR is of prime importance in the pathogenesis of absence epilepsy because of its apparent role in the synchronization and desynchronization of thalamocortical circuitry. Perturbation of this process leads to the generation of absence seizures. The oscillatory burst firing of thalamocortical circuitry is attributed to the ability of neurons located in the nucleus reticularis thalami (nRT) to impose their own oscillatory behavior on thalamocortical relay neurons located in the ventral basalis (VB) of the thalamus. The ability of the nRT to switch between oscillatory and burst firing dictates electroencephelographic (EEG) synchronization and desynchronization. The nRT consists of GABAergic neurons that project to the VB, providing inhibitory input. Also, GABAergic nRT neurons project onto one another providing intra-nRT inhibition, which decreases input to the VB. The nRT GABAergic neurons receive glutamatergic inputs from thalamocortical VB fibers and also from corticothalamic fibers projecting back from layer VI of the cerebral cortex 10, 11, 12, 13, 14, 15, 16, 17. Within this circuitry, GABAAR are located on glutamatergic thalamocortical and corticothalamic neurons as well as GABAergic nRT neurons.

The localization of GABAAR subunit proteins have revealed a complementary distribution within thalamocortical circuitry. The nRT is rich in α1 α3, β1, β3, and γ2 subunits and is virtually devoid of β2 and δ subunits. In contrast, the thalamic relay neurons have high levels of α1, α4, β2, δ subunits but show no detectable levels of the β3 subunit(7). Electrophysiological studies have indicated that inhibitory postsynaptic currents differ in the nRT and thalamic relay neurons 18 a functional difference likely due to the distinct population of GABAAR subunits in each region.

The action of benzodiazepines within thalamocortical circuitry illustrates further the functional differences between GABAAR localized to the nRT versus those found on thalamic relay neurons. Systematic stimulation of GABAAR within thalamocortical circuitry via administration of GABAAR agonists, GABA transaminase inhibitors, or GABA reuptake inhibitors causes an exacerbation of the duration of spike-and-wave discharge (SWD) in pharmacological and genetic animal models of absence seizures 19, 20, 21, 22, 23. Because benzodiazepines augment GABAAR-mediated neurotransmission, these compounds would be predicted to exacerbate absence seizures in a similar fashion; however, this class of drugs has been shown to have both experimental and clinical therapeutic efficacy in the treatment of absence seizures. The reason for this dichotomy is that benzodiazepines enhance GABAAR-mediated inhibition within the nRT, resulting in a decreased inhibition by the nRT of thalamic relay neurons 24. This specificity of action of benzodiazepines on nRT GABAAR may be explained by the tissue-specific subunit composition of GABAAR within the nRT versus those within thalamic relay nuclei. A large number of thalamic relay nuclei contain GABAAR comprised of the δ subunit; however, GABAARs containing the δ subunit are known to be benzodiazepine insensitive. Furthermore, many GABAAR in thalamic nuclei contain the benzodiazepine-insensitive α4 subunit. Conversely, in the nRT, a large number of GABAAR contain a benzodiazepine-sensitive γ2 subunit in place of the δ subunit, as well as the benzodiazepine-sensitive α3 subunit(7).

Thalamocortical GABAAR and Absence Seizures

Microinjection studies in the genetic absence epilepsy rats from Strasbourg (GAERS) have helped to define the role of GABAAR in the thalamocortical circuitry in the pathogenesis of absence seizures in this genetic model. Application of γ-vinyl GABA (GVG), an irreversible GABA transaminase inhibitor, into the nRT increases intra-nRT inhibition and results in less inhibitory input onto thalamic relay neurons. The net result is an inhibition of SWD and attenuation of absence seizures. Conversely, the administration of GVG into thalamic relay nuclei activates GABAAR on the thalamic relay neurons, resulting in increased inhibitory input and exacerbation of the absence seizures 25.

While GABAAR agonists exacerbate absence seizures, GABAAR antagonists, such as pentylenetetrazole, bicuculline, and picrotoxin, fail to block experimental absence seizures 21. Administration of GABAAR antagonists induce a dose-dependent continuum of seizure types. Low doses induce absence-like seizures; intermediate doses produce clonic seizures responsive to antiabsence drugs, and high doses induce tonic seizures unresponsive to antiabsence drugs 26, 27, 28, 29. Administration of low dose GABAAR antagonists directly into the nRT results in the enhanced oscillatory synchrony observed in absence seizures, whereas application of GABAAR antagonists to the relay neurons had no effect 30. However, recently Staak and Pape reported that microinjection of bicuculline into the thalamic relay neurons exacerbated SWD in the WAG/Rij rat model of absence epilepsy 31.

The data suggest that low dose GABAAR antagonist-induced absence seizures result from the involvement of GABAAR within the nRT which mediate a decrease in intra-nRT inhibition. Mutagenesis studies have revealed that two key residues in the second transmembrane domain of the β3 subunit are essential for high-affinity antagonist binding of tert-butylbicyclophosphorothionate and picrotoxin 32, 33. The fact that this high-affinity antagonist binding β3 subunit is present in the nRT and not on the thalamic relay neurons may explain the nRT-specific effect of low-dose GABAAR antagonists in their ability to precipitate absence seizures.

Recently, a mutation in the γ2 subunit has been linked to childhood absence of epilepsy and febrile seizures 34. In vitro replication of this mutation in recombinant receptors revealed an abolished sensitivity to diazepam. The γ2 mutation would be predicted to render GABAAR in the nRT benzodiazepine-insensitive and thus would be unable to augment intra-nRT inhibition. This study strengthens the concept that physiologically relevant endogenous benzodiazepines exist and play an important role in the prevention of absence seizures in humans.

GABAAR Mutant Mice

Subunit-Specific Knockouts

Valuable insights regarding GABAAR-mediated inhibition, subunit assembly, and receptor trafficking have been gained from studies in which the gene for a single subunit has been disrupted, and effectively deleted 35. Currently, knockout mice have been reported for α1, α6, β2, β3, δ, and γ2 subunits. Decreased surface expression of the δ subunit in α6 knockouts concurs with in vitro data indicating preferential assembly of these two subunits 36. In addition, the decreased surface expression of all six α subunits in the β2 knockout mice suggests that the β2 subunit assembles with all six subunits 37.

The major limitations inherent in the gene disruption technique that constrain our ability to interpret phenotypes resulting from knockout techniques are those developmental mechanisms that emerge to compensate for the absence of the gene of interest. For example, although the δ knockout mice displays attenuated sensitivity to the modulatory effects of neurosteroid, there is an associated upregulation of those GABAAR containing the γ2 subunit 38. Similarly, α6 knockout mice have increased sensitivity to diazepam-induced motor impairment, but there is an associated increase in β3-containing GABAAR, as well as an upregulation of a K+ channel (TASK-1) in granule cells.

Near-lethal gene disruptions also present interpretive problems. The β3 and γ2 knockout mice exhibit extremely high mortality rates, with only a minor percentage of pups surviving. Several of the knockout mice contain a neomycin-resistance cassette used in the gene disruption procedure. This cassette has been shown to impart inhibitory influences on neighboring genes in several nonneuronal systems 39, 40, 41. This scenario is likely to explain the widespread decrease of α1 and β2 expression observed in the α6−/− mice because the three subunit genes are located next to each other, in a gene cluster 42. This problem can be avoided in future mutants by strategic removal of the neomycin resistance gene following the creation of the mutant mice, as has been done in the α1−/− and β2−/− mice 12.

Subtype Specific Benzodiazepine Binding and Knock-In Point Mutation Mice

Benzodiazepines bind to the modulatory site on the GABAAR in a high-affinity (nM) and low-affinity (uM) manner 43. The GABAAR with the classic high-affinity benzodiazepine binding site contains an α, β, γ subunit combination. Recombinant receptor studies have indicated that the binding site is located between the interface of the α and γ subunits and that the α subunit is restricted to α1, α2, α3, and α5 44. No benzodiazepine binding is detectable in γ2−/− mice 45.

Recently, single amino acid substitutions in GABAAR subunits have been incorporated into germlines of mice. This method alters one pharmacological aspect of a subunit while closely preserving the native GABAAR composition, hence preventing developmental and compensatory in vivo responses to a missing subunit. The benzodiazepine-sensitive α1, α2, α3, and α5 subunits have a conserved histidine amino acid residue in the binding domain, whereas benzodiazepine-insensitive α4 and α6 subunits have an arginine at the equivalent residue. Point mutations converting the histidine to arginine rendered benzodiazepine-sensitive α subunits to be insensitive in vitro. When this point mutation was made in the α1 subunit of a mutant mouse line, benzodiazepines failed to induce sedation and anterograde amnesia and had a reduced anticonvulsant potency 46, 47. However, neither diazepam-induced inhibition of REM sleep nor the effect of diazepam on EEG during sleep and wakefulness were altered in the α1 mutants 48. Similar mutations in the α2 and α3 subunits revealed that α2- and not α3-containing receptors mediated the anxiolytic response to benzodiazepines 49.

Relevance of GABAA Mutant Mice to Absence Seizures

Studies of β3−/− mice have provided valuable insight into the role of this subunit in thalamocortical circuitry. GABAAR-mediated inhibition was essentially abolished within the nRT, but was unaffected in the thalamic relay neurons. This observation is in agreement with the restricted expression of β3 containing GABAAR, in thalamic relay nuclei where the neurons contain primarily the β2 subunit. In addition, oscillatory synchrony was greatly intensified in the β3−/− mice. These observations strongly suggest that recurrent inhibitory connections within the nRT act as desynchronizers in thalamocortical circuitry and that β3 containing GABAAR are primarily responsible for GABAAR-mediated intra-nRT inhibition in vivo 30.

The β2−/− mice are an intriguing mutant because loss of the major β subunit in the CNS results in an ∼ 60% loss of GABAAR throughout the brain; however, neither an overt phenotype nor spontaneous seizures are apparent 37. This lack of a demonstrable phenotype may be explained partially by the existence and potential functional overlap of β2 with other β subunits in many neurons. In thalamocortical circuitry, the relay neurons of the β2−/− mice appear to contain only low levels of the β1 subunit.

Similarly, δ2/− mice are of particular interest because of the restricted expression of δ containing GABAAR in the thalamic relay neurons of the VB versus nRT neurons. These mutant mice are reported to have attenuated responses to neuroactive steroids 38. There are few published data available regarding the effects of chemically induced absence seizures in δ2/− mice. Neuroactive steroids have been shown to potentiate low-dose pentylenetetrazole-induced absence in δ1/+ but not δ2/− mice; however, absence seizure activity was measured in these studies by observation of hypoactivity rather than by the more precise method of EEG quantitation.

ACKNOWLEDGMENTS

This work was supported in part by the Canadian Institutes of Health Research and the Bloorview Childrens Hospital Foundation.

References

  • 1.Sieghart W. Structure and pharmacology of γ-aminobutyric acidA receptor subtypes. Pharmacol Rev 1995;47:181–234. [PubMed] [Google Scholar]
  • 2.Barnard EA. International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998;50:291–313. [PubMed] [Google Scholar]
  • 3.Sieghart W, Fuchs K, Tretter V, Ebert V, Jechlinger M, Hoger H, Adamiker D. Structure and subunit composition of GABAA receptors. Neurochem Int 1999;34:379–85. [DOI] [PubMed] [Google Scholar]
  • 4.Bonnert TP, McKernan RM, Farrar S, le Bourdeles B, Heavens RP, Smith DW, Hewson L, Rigby MR, Sirinathsinghji JS, Brown N, Wafford KA, Whiting PJ. θ, a novel γ-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci USA 1999;86:9891–9896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Barnes EM, Jr.. Intracellular trafficking of GABAA receptors. Life Sci 2000;66:1063–1070. [DOI] [PubMed] [Google Scholar]
  • 6.McKernan RM, Whiting PJ. Which GABAA receptor subtypes really occur in the brain? Trends Neurosci 1996;19:139–143. [DOI] [PubMed] [Google Scholar]
  • 7.Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000;101:815–850. 10.1016/S0306-4522(00)00442-5 [DOI] [PubMed] [Google Scholar]
  • 8.Fritschy JM, Weinmann O, Wenzel A, Benke D. Synapse-specific localization of NMDA and GABAA receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 1998;390:194–210. [DOI] [PubMed] [Google Scholar]
  • 9.Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 1998;18:1693–1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Steriade M, Llinas RR. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 1988;68:649–742. [DOI] [PubMed] [Google Scholar]
  • 11.Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science 1993;262:679–685. [DOI] [PubMed] [Google Scholar]
  • 12.Steriade M, Parent A, Haha J. Thalamic projections of nucleus reticularis thalami of cat: a study using retrograde transport of horseradish peroxidase and fluorescent tracers. J Comp Neurol 1984;229: 531–547. [DOI] [PubMed] [Google Scholar]
  • 13.Yen CT, Conley M, Hendry SHC, Jones EG. The morphology of physiologically identified GABA-ergic neurons in the somatic sensory part of the thalamus reticular nucleus in the cat. J Neurosci 1985;5:2254–2268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cronwall J, Cooper JD, Phillipson OT. Projections to the rostral reticular thalamic neurons in the rat. Exp Brain Res 1990;80:157–171. [DOI] [PubMed] [Google Scholar]
  • 15.Spreafico R, Battaglia G, Frassoni C. The reticular thalamic nucleus (RTN) of the rat: cytoarchitechtural, Golgi, immunocytochemical, and horseradish peroxidase study. J Comp Neurol 1991;304:478–490. [DOI] [PubMed] [Google Scholar]
  • 16.von Krosigk M, Monckton J, Reiner P, McCormick DA. Cellular mechanisms of a synchronized oscillation in the thalamus. Science 1993;261:361–364. [DOI] [PubMed] [Google Scholar]
  • 17.McCormick DA, Bal T. Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 1997;20:185–215. [DOI] [PubMed] [Google Scholar]
  • 18.Zhang SJ, Huguenard JR, Prince DA. GABAA receptor-mediated Cl-currents in rat thalamic reticular and relay neurons. J Neurophysiol 1997;78:2280–6876876. [DOI] [PubMed] [Google Scholar]
  • 19.Snead OC. γ-Hydroxybutyric acid, γ-aminobutyric acid, and petit mal epilepsy. In: Fariello RG, Morseli PL, Lloyd KG, Quesney LF, Engel J. Neurotransmitters, seizures, and epilepsy II. : Raven Press, 1984:37–47. [Google Scholar]
  • 20.Snead OC. The ontogeny of GABA-ergic enhancement of the γ-hydroxybutyrate model of generalized absence seizures. Epilepsia 1990;31:253–258. [DOI] [PubMed] [Google Scholar]
  • 21.Smith KA, Bierkamper GG. Paradoxical role of GABA in a chronic model of petit mal (absence)-like epilepsy in the rat. Eur J Pharmacol 1990;176:46–55. [DOI] [PubMed] [Google Scholar]
  • 22.Vergnes M, Marescaux C, Michelettis G, Depaulis A, Rumbach L, Warter JM. Enhancement of spike and wave discharge by GABA-mimetic drugs in rat with spontaneous petit mal-like epilepsy. Neurosci Lett 1984;44:91–94. [DOI] [PubMed] [Google Scholar]
  • 23.Peeters BWMM, van Rijn CM, Vossen JMH, Coenen AML. Effects of GABA-ergic agents on spontaneous non-convulsive epilepsy: EEG and behavior, in the WAG/Rij inbred strain of rats. Life Sci 1989;45:1171–1176. [DOI] [PubMed] [Google Scholar]
  • 24.Huguanard JR, Prince DA. Clonazepam suppresses GABAB mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J Neurophysiol 1994;71:2576–2581. [DOI] [PubMed] [Google Scholar]
  • 25.Liu Z, Verges M, Depaulis A, Marescaux C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Res 1991;545:1–7. [DOI] [PubMed] [Google Scholar]
  • 26.Marescaux C, Micheletti G, Vergnes M, Depaulis A, Rumbach L, Warter JM. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures. Epilepsia 1984;25:326–331. [DOI] [PubMed] [Google Scholar]
  • 27.Snead OC. The γ-hydroxybutyrate model of absence seizures: further characterization and comparison with other absence models. Epilepsia 1988;29:361–368. [DOI] [PubMed] [Google Scholar]
  • 28.Snead OC, Banerjee PK, Burnham M, Hampson D. Modulation of absence seizures by the GABAAR: A critical role for metabotropic glutamate receptor 4 (mGluR4). J Neurosci 2000;20:6218–6224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Matejovska I, Veliskova J, Velisek L. Bicuculline-induced rhythmic EEG episodes as a model of absence seizures: gender differences and the effects of ethosuximide and baclofen treatment. Epilepsia 1998;39:1243–1252. [DOI] [PubMed] [Google Scholar]
  • 30.Huntsman MM, Porcello DM, Homanics GE, Delorey TM, Huguenard JR. Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 1999;283:541–543. 10.1126/science.283.5401.541 [DOI] [PubMed] [Google Scholar]
  • 31.Staak R, Pape H-C. Contribution of GABAA and GABAB receptors to thalamic neuronal activity during spontaneous absence seizures in rats. J Neurosci 2001;21:1378–1384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jursky F, Fuchs K, Buhr A, Tretter V, Sigel E, Sieghart W. Identification of amino acid residues of GABAA receptor subunits contributing to the formation and affinity of the tert-Butylbicyclophosphorothionate binding site. J Neurochem 2000;74:1310–1316. [DOI] [PubMed] [Google Scholar]
  • 33.Buhr A, Wagner C, Fuchs K, Sieghart W, Sigel E. Two novel residues in M2 of the γ-Aminobutyric acid type A receptor affecting gating by GABA and picrotoxin affinity. J Biol Chem 2001;276:7775–7781. [DOI] [PubMed] [Google Scholar]
  • 34.Wallace RH, Marini C, Petron S, Harkin LA, Bowser DN, Panchal RG, Williams DA, Sutherland GR, Mulley JC, Scheffer IE, Berkovic SF. Mutant GABAA receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001;28:49–52. [DOI] [PubMed] [Google Scholar]
  • 35.Mohler H, Luscher B, Fritschy JM, Benke D, Benson J, Rudolph U. GABAA-receptor assembly in vivo: lessons from subunit mutant mice. Life Sciences 1998;62:1611–1615. 10.1016/S0024-3205(98)00116-7 [DOI] [PubMed] [Google Scholar]
  • 36.Jones A, Korpi ER, McKernan RM, Pelz R, Nusser SZ, Makela R, Mellor JR, Pollard S, Bahn S, Stephanson FA, Randall AD, Sieghart W, Somogyi P, Smith AJH, Wisden W. Ligand-gated ion channel subunit partnerships: GABAA receptor α6 subunit gene inactivation inhibits δ subunit expression. J Neurosci 1997;17:1350–1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cyrille Sur KA, Wafford DS, Reynolds KL, Hadingham FB, Macauley A, Collinson N, O'Meara G, Howell O, Newman R, Myers J, Atack JR, Dawson GR, McKernan RM, Whiting PJ, Rosahl TW. Loss of the major GABAA receptor subtype in the brain is not lethal in mice. J Neurosci 2001;21:3409–3418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mihalek RM, Banerjee PK, Korp ER, Quinlan JJ, Firestone LL, Mi ZP, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, Sage JR, Fanselow MS, Guidotti A, Spigelman I, Li Z, Delorey TM, Olsen RW, Homanics GE. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci USA 1999;96:12905–12910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Fiering S, Epner E, Robinson K, Zhuang T, Telling A, Hu M, Martin DI, Enver T, Ley TJ, Groudine M. Targeted deletion of 5′HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev 1995;9:2203–2213. [DOI] [PubMed] [Google Scholar]
  • 40.Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA 1996;93:13090–13095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.van Ree JH, van der Broek WJ, van der Zee A, Dahlmans VE, Wieringa B, Frants RR, Havekes LM, Hofker MH. Inactivation of APOE and APOC1 by two consecutive rounds of gene targeting: Effects on mRNA expression levels of gene cluster members. Hum Mol Genet 1995;4:1403–1409. [DOI] [PubMed] [Google Scholar]
  • 42.Uusi-Oukari M, Heikkila J, Sinkkonen ST, Makela R, Hauer B, Homanics GE, Sieghart W, Wisden W, Korpi ER. Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABAA receptor β2-α6-α1-γ2 subunit gene cluster. Mol Cell Neurosci 2000;16:34–41. 10.1006/mcne.2000.0856 [DOI] [PubMed] [Google Scholar]
  • 43.Walters RJ, Hadley SH, Morris KDW, Amin J. Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nat Neurosci 2000;3:1274–1281. [DOI] [PubMed] [Google Scholar]
  • 44.Sigel E, Buhr A. The benzodiazepine binding site of GABAA receptors. Trends Pharmacol Sci 1997;18:425–429. [DOI] [PubMed] [Google Scholar]
  • 45.Gunther U, Benson J, Benke S, Fritschy JM, Reyes G, Knoflach F, Crestani F, Aguzzi A, Arigoni M, Lang Y, Bluethmann H, Mohler H, Luscher B. Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 1995;92:7749–7753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Mohler H. Benzodiazepine actions mediated by specific γ-aminobutyric acid A receptor subtypes. Nature 1999;401:796–800. 10.1038/44579 [DOI] [PubMed] [Google Scholar]
  • 47.McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers S, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype. Nat Neurosci 2000;3:587–592. 10.1038/75761 [DOI] [PubMed] [Google Scholar]
  • 48.Tobler I, Kopp C, Deboer T, Rudolph U. Diazepam-induced changes in sleep: Role of the alpha 1 GABAA receptor subtype. Proc Natl Acad Sci USA 2001;98:6464–6469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000;290:131–134. [DOI] [PubMed] [Google Scholar]

Articles from Epilepsy Currents are provided here courtesy of American Epilepsy Society

RESOURCES